Evidence map›Paper›PMID 32507460›Full record

ArticleJournal of cardiothoracic and vascular anesthesia2020

Supraglottic Airway Use for Transfemoral-Transcatheter Aortic Valve Replacement.

Shara S Azad, Frederick C Cobey, Lori Lyn Price, Roman Schumann, Alexander D Shapeton

Open access · greenAbstract read
In one paragraph

Article in Journal of cardiothoracic and vascular anesthesia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shara S AzadDepartment of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, MA.
Frederick C CobeyDepartment of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, MA.
Lori Lyn PriceTufts Clinical and Translational Science Institute, Tufts University, Boston, MA; Institute of Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.
Roman SchumannTufts University School of Medicine, Boston, MA; Department of Anesthesia, Critical Care and Pain Medicine, Boston Veterans Affairs Health Care System, West Roxbury, MA.
Alexander D ShapetonTufts University School of Medicine, Boston, MA; Department of Anesthesia, Critical Care and Pain Medicine, Boston Veterans Affairs Health Care System, West Roxbury, MA. Electronic address: alexander.shapeton@va.gov.
Tufts University · USTufts Medical Center · US

Funding

Tufts Clinical and Translational Science Institute (Pilot Supplement)UL1TR002544 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2018 to 2022
$50.2M
NCATS NIH HHS UL1 TR002544
6 · The paper itself

Abstract

objectiveExamine outcome differences in patients managed either with a supraglottic airway or an endotracheal tube for general anesthesia during transcatheter aortic valve replacement. The authors hypothesized that patients managed with a supraglottic airway would have shorter post-anesthesia care unit and hospital stays and receive fewer opioids, norepinephrine equivalents, and neuromuscular blocking agents, without an increase in 30-day major adverse cardiovascular events.

designRetrospective chart review with 1:2 supraglottic airway-to-endotracheal tube patient propensity score matching.

settingSingle, urban, tertiary care, academic medical center.

participantsPatients undergoing transfemoral- transcatheter aortic valve replacement between 2017 and 2019.

interventionsSupraglottic or endotracheal tube airway management during general anesthesia. MEASUREMENTS AND MAIN

resultsThirty-one supraglottic airway patients were propensity score matched with 62 endotracheal tube patients. There was no significant difference for postanesthesia care unit (p = 0.58) or hospital (p = 0.16) lengths of stay. Supraglottic airway patients received significantly fewer neuromuscular blockers (p < 0.0001) and trended toward fewer opioids (p = 0.05), but received a similar number of norepinephrine equivalents (p = 0.76). The major adverse cardiovascular event odds ratio between groups was 1.39 (p = 0.51). The time under general anesthesia (p = 0.02) and total time in the operating room (p = 0.04) were significantly shorter for supraglottic airway patients.

conclusionsSupraglottic airway management in transcatheter aortic valve replacement was feasible without an increase in major adverse cardiovascular outcomes compared with endotracheal tube management during general anesthesia. Supraglottic airway patients trended toward receiving fewer opioids and received significantly fewer neuromuscular blockers while also having significantly shorter time under general anesthesia and total time in the operating room.

Indexed as

Aortic Valve StenosisTranscatheter Aortic Valve ReplacementAnesthesia, GeneralAortic ValveHumansLength of StayRetrospective StudiesRisk FactorsTreatment Outcomeaortic valveendotracheal tubeETTlaryngeal mask airwayLMAsupraglottic airwayTAVRTEEtranscatheter aortic valve replacementtransesophageal echocardiography

Identifiers

PMID32507460
PMCPMC7837407
OpenAlexW3025919946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.